Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Yun Dai, Munawaer Muaibati, Weiming Xie, Abuduyilimu Abasi, Kexin Li, Qing Tong, Tao Zhang, Yifan Meng, Liang Zhuang & Xiaoyuan Huang. (2022) PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review. Cancer Investigation 40:3, pages 293-309.
Read now
Read now
Marie Beck Enemark, Ida Monrad, Charlotte Madsen, Kristina Lystlund Lauridsen, Bent Honoré, Trine Lindhardt Plesner, Stephen Jacques Hamilton-Dutoit, Francesco d’Amore & Maja Ludvigsen. (2021) PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation. OncoTargets and Therapy 14, pages 481-489.
Read now
Read now
Shanshan Yu, Luya Cai, Fan Lin, Xueyuan Wu, Cheng Zhang, Xuan Liu & Wenfeng Li. (2019) Durable Response After Combination Of Concurrent Chemoradiotherapy And Anti-PD-1 Therapy In HER2-Negative Advanced Gastric Adenocarcinoma: A Case Report. OncoTargets and Therapy 12, pages 7691-7698.
Read now
Read now
Weili Xue, Weiming Li, Tiantian Zhang, Zhaoming Li, Yingjun Wang, Yajuan Qiu, Yuanyuan Wang, Changying Chen, Dongjun Fu & Mingzhi Zhang. (2019) Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway. OncoTargets and Therapy 12, pages 2079-2088.
Read now
Read now
Kazuhiro Mochizuki, Satoshi Kawana, Shoki Yamada, Moe Muramatsu, Hideki Sano, Shogo Kobayashi, Yoshihiro Ohara, Nobuhisa Takahashi, Michiyuki Hakozaki, Hitoshi Yamada, Yuko Hashimoto & Atsushi Kikuta. (2019) Various checkpoint molecules, and tumor-infiltrating lymphocytes in common pediatric solid tumors: Possibilities for novel immunotherapy. Pediatric Hematology and Oncology 36:1, pages 17-27.
Read now
Read now
David J. Pinato, James R. Black, Sebastian Trousil, Roberto E. Dina, Pritesh Trivedi, Francesco A. Mauri & Rohini Sharma. (2017) Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior. OncoImmunology 6:11.
Read now
Read now
Manuele G. Muraro, Simone Muenst, Valentina Mele, Luca Quagliata, Giandomenica Iezzi, Alexandar Tzankov, Walter P. Weber, Giulio C. Spagnoli & Savas D. Soysal. (2017) Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments. OncoImmunology 6:7.
Read now
Read now
Massimo Martino, Moreno Festuccia, Roberta Fedele, Giuseppe Console, Michele Cimminiello, Paolo Gavarotti & Benedetto Bruno. (2016) Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents. Expert Opinion on Biological Therapy 16:3, pages 347-364.
Read now
Read now
Articles from other publishers (65)
Subarnarekha Maitra, Debarati Bhattacharya, Souvik Paul, Payel Ghosh Chowdhury, Dipanjan Mandal, Pallab Kanti Haldar, Ashok Kumar Balaraman & Asis Bala. (2023) Programmed Cell Death Protein 1 (PD-1) in Relation to PANoptosis: Immune
Pharmacological Targets for Management of Breast Adenocarcinoma. Endocrine, Metabolic & Immune Disorders - Drug Targets 23:13, pages 1571-1585.
Crossref
Crossref
Giuseppe Angelico, Giuseppe Broggi, Giordana Tinnirello, Lidia Puzzo, Giada Maria Vecchio, Lucia Salvatorelli, Lorenzo Memeo, Angela Santoro, Jessica Farina, Antonino Mulé, Gaetano Magro & Rosario Caltabiano. (2023) Tumor Infiltrating Lymphocytes (TILS) and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist’s Perspective. Cancers 15:18, pages 4479.
Crossref
Crossref
Wenqiang Li, Mei Li, Qian Huang, Xiaoyu He, Chen Shen, Xiaoming Hou, Fulai Xue, Zhiping Deng & Yao Luo. (2023) Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug. Frontiers in Chemistry 11.
Crossref
Crossref
Anze Yu, Xiaowen Xu, Yingxian Pang, Minghao Li, Junhang Luo, Jing Wang & Longfei Liu. (2023) PD-L1 Expression is Linked to Tumor-Infiltrating T-Cell Exhaustion and Adverse Pathological Behavior in Pheochromocytoma/Paraganglioma. Laboratory Investigation 103:9, pages 100210.
Crossref
Crossref
Chong Chen, Huaru Yin, Yu Zhang, Huan Chen, Jie Xu & Li Ren. (2023)
Plasma D‐dimer and interleukin‐6 are associated with treatment response and progression‐free survival in advanced
NSCLC
patients on anti‐
PD
‐1 therapy
. Cancer Medicine 12:15, pages 15831-15840.
Crossref
Crossref
Shoma Nishibori, Mika K. Kaneko, Takayuki Nakagawa, Kazuo Nishigaki, Yukinari Kato, Masaya Igase & Takuya Mizuno. (2023) Development of anti-feline PD-1 antibody and its functional analysis. Scientific Reports 13:1.
Crossref
Crossref
Serena Martinelli, Francesca Amore, Letizia Canu, Mario Maggi & Elena Rapizzi. (2023) Tumour microenvironment in pheochromocytoma and paraganglioma. Frontiers in Endocrinology 14.
Crossref
Crossref
Alessandra Dimino, Chiara Brando, Laura Algeri, Valerio Gristina, Erika Pedone, Marta Peri, Alessandro Perez, Ida De Luca, Roberta Sciacchitano, Luigi Magrin, Tancredi Didier Bazan Russo, Marco Bono, Nadia Barraco, Silvia Contino, Maria La Mantia, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan & Lorena Incorvaia. (2022) Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors. Cancers 15:1, pages 216.
Crossref
Crossref
Kexin Li, Huan Yu, Zhihong Bao, Lu Xu, Hong Zhang, Tian Wang, Longyue Yu & Yue Yuan. (2022) Combination of photosensitizer and immune checkpoint inhibitors for improving the efficacy of tumor immunotherapy. International Journal of Pharmaceutics 629, pages 122384.
Crossref
Crossref
Yao Chen, Bingjun Bai, Kangkang Ying, Hongming Pan & Binbin Xie. (2022) Anti-PD-1 combined with targeted therapy: Theory and practice in gastric and colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:5, pages 188775.
Crossref
Crossref
Ubaid Ahmad, Zafran Khan, Daniya Ualiyeva, Obed Boadi Amissah, Zohaib Noor, Asaf Khan, Nasib Zaman, Marwa Khan, Ayub Khan & Babar Ali. (2022) Chimeric antigen receptor T cell structure, its manufacturing, and related toxicities; A comprehensive review. Advances in Cancer Biology - Metastasis 4, pages 100035.
Crossref
Crossref
Jun Zhang, Lin Chen, Qin Xu, Yue Tao, Jie Pan, Jianmin Guo, Jing Su, Hui Xie & Yuxin Chen. (2022) An automated, rapid fluorescent immunoassay to quantify serum soluble programmed death-1 (PD-1) protein using testing-on-a-probe biosensors. Clinical Chemistry and Laboratory Medicine (CCLM) 60:7, pages 1073-1080.
Crossref
Crossref
Geethu S Kumar, Mahmoud Moustafa, Amaresh Kumar Sahoo, Petr Malý & Shiv Bharadwaj. (2022) Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy. Life 12:5, pages 659.
Crossref
Crossref
Shaowen Li, Chunli Dong, Jiayan Chen, Xiaocui Gao, Xiuying Xie & Xin Zhang. (2021) Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma. Aging.
Crossref
Crossref
Ying Wang, Na Shen, Yue Wang, Mo Li, Wanze Zhang, Liwen Fan, Linlin Liu, Zhaohui Tang & Xuesi Chen. (2021) Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy. Biomaterials Science 9:8, pages 3019-3027.
Crossref
Crossref
Thomas Menter, Alexandar Tzankov & Stefan Dirnhofer. (2020) The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors. Hematological Oncology 39:1, pages 3-10.
Crossref
Crossref
Guangjie Liao, Jingqiu Yang & Xinke Zhang. (2021) Review of the application of dMMR and microsatellite instability in the diagnosis and treatment of endometrial cancer. Annals of Oncology Research and Therapy 1:2, pages 71.
Crossref
Crossref
Giuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, Tullio Florio, Tiziana Feola, Manila Rubino, Federica de Cicco, Annamaria Colao & Antongiulio Faggiano. (2020) Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks. Journal of Clinical Medicine 10:1, pages 88.
Crossref
Crossref
Priyadarshini Kumar, Qi Gao, Alexander Chan, Natasha Lewis, Allison Sigler, Janine Pichardo, Wenbin Xiao, Mikhail Roshal & Ahmet Dogan. (2020) Hairy cell leukemia expresses programmed death-1. Blood Cancer Journal 10:11.
Crossref
Crossref
Salman M. Toor, Varun Sasidharan Nair, Julie Decock & Eyad Elkord. (2020) Immune checkpoints in the tumor microenvironment. Seminars in Cancer Biology 65, pages 1-12.
Crossref
Crossref
Sevda Jafari, Ommoleila Molavi, Houman Kahroba, Mohammad Saied Hejazi, Nasrin Maleki-Dizaji, Siamak Barghi, Seyed Hossein Kiaie & Farhad Jadidi-Niaragh. (2020) Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer. Cellular and Molecular Life Sciences 77:19, pages 3693-3710.
Crossref
Crossref
Chaoyue Su, Hui Wang, Yunru Liu, Qiaoru Guo, Lingling Zhang, Jiajun Li, Wenmin Zhou, Yanyan Yan, Xinke Zhou & Jianye Zhang. (2020) Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Bo Hu, Li Niu, Zheng Jiang, Shenglin Xu, Yong Hu & Kun Cao. (2020) LncRNA XLOC_003810 promotes T cell activation and inhibits PD‐1/PD‐L1 expression in patients with myasthenia gravis‐related thymoma. Scandinavian Journal of Immunology 92:1.
Crossref
Crossref
Shiguang Peng, Mei Cao, Xiaoying Sun, Yaqiong Zhou, Chu‑Yen Chen, Tian Ma, Hongjin Li, Bin Li, Bo Zhu & Xin Li. (2020) Recombinant programmed cell death 1 inhibits psoriatic inflammation in imiquimod‑treated mice. International Journal of Molecular Medicine.
Crossref
Crossref
Artur Wnorowski, Sylwia Wnorowska, Kamila Wojas-Krawczyk, Anna Grenda, Michał Staniak, Agnieszka Michalak, Sylwia Woźniak, Dariusz Matosiuk, Grażyna Biała, Magdalena Wójciak, Ireneusz Sowa, Paweł Krawczyk & Maciej Strzemski. (2020) Toxicity of Carlina Oxide—A Natural Polyacetylene from the Carlina acaulis Roots—In Vitro and in Vivo Study. Toxins 12:4, pages 239.
Crossref
Crossref
Jie Huang & Jian Jian Li. 2020. Tumor Microenvironment. Tumor Microenvironment
175
202
.
Liang Yan, Zhen Wang, Can Cui, Xiaoya Guan, Bin Dong, Min Zhao, Jianhui Wu, Xiuyun Tian & Chunyi Hao. (2019) Comprehensive immune characterization and T‐cell receptor repertoire heterogeneity of retroperitoneal liposarcoma. Cancer Science 110:10, pages 3038-3048.
Crossref
Crossref
Andrew R. Clark & Michael Ohlmeyer. (2019) Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration. Pharmacology & Therapeutics 201, pages 181-201.
Crossref
Crossref
Li Fan, Yue Li, Jia-Yu Chen, Yong-Fa Zheng & Xi-Ming Xu. (2019) Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales. Cancer Letters 456, pages 23-28.
Crossref
Crossref
Emilio Francesco Giunta, Giuseppe Argenziano, Gabriella Brancaccio, Erika Martinelli, Fortunato Ciardiello & Teresa Troiani. (2019) Beyond PD-1/PD-L1 Axis Blockade: New Combination Strategies in Metastatic Melanoma Treatment. Current Cancer Therapy Reviews 15:2, pages 110-119.
Crossref
Crossref
Lorenzo Castagnoli, Valeria Cancila, Sandra L. Cordoba-Romero, Simona Faraci, Giovanna Talarico, Beatrice Belmonte, Marilena V. Iorio, Matteo Milani, Tatiana Volpari, Claudia Chiodoni, Alfredo Hidalgo-Miranda, Elda Tagliabue, Claudio Tripodo, Sabina Sangaletti, Massimo Di Nicola & Serenella M. Pupa. (2019) WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer. Oncogene 38:21, pages 4047-4060.
Crossref
Crossref
Anna Grenda, Marcin Nicoś, Michał Szczyrek, Paweł Krawczyk, Tomasz Kucharczyk, Bożena Jarosz, Juliusz Pankowski, Marek Sawicki, Justyna Szumiło, Paulina Bukała & Janusz Milanowski. (2019) MicroRNAs aid the assessment of programmed death ligand�1 expression in patients with non‑small cell lung cancer. Oncology Letters.
Crossref
Crossref
Thomas Menter & Alexandar Tzankov. (2018) Genetic alterations of 9p24 in lymphomas and their impact for cancer (immuno-)therapy. Virchows Archiv 474:4, pages 497-509.
Crossref
Crossref
Chang-Eun Park & Sung-Ha Park. (2019) Investigation of the Molecular Diagnostic Market in Animals. The Korean Journal of Clinical Laboratory Science 51:1, pages 26-33.
Crossref
Crossref
Nicole A Carreau & Anna C Pavlick. (2019) Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma. Future Oncology 15:4, pages 349-358.
Crossref
Crossref
Ya-Xin Huang, Qi-Yi Zhao, Li-Li Wu, Dong-Ying Xie, Zhi-Liang Gao & Hong Deng. (2018)
Increased CCR
PD-
CXCR
CD
T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection
. Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-9.
Crossref
Crossref
Peter Hollander, Rose-Marie Amini, Beatrice Ginman, Daniel Molin, Gunilla Enblad & Ingrid Glimelius. (2018) Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma. PLOS ONE 13:9, pages e0204870.
Crossref
Crossref
Reza B Jalili, Ruhangiz T Kilani, Yunyuan Li, Mohsen Khosravi-maharlooie, Layla Nabai, Eddy Hsi Chun Wang, Kevin J McElwee & Aziz Ghahary. (2018) Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model. Cell Transplantation 27:6, pages 994-1004.
Crossref
Crossref
Michael Rückert, Lisa Deloch, Rainer Fietkau, Benjamin Frey, Markus Hecht & Udo S. Gaipl. (2018) Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapiesImmunmodulierende Eigenschaften von Radiotherapie als Basis für wohldurchdachte Radioimmuntherapien. Strahlentherapie und Onkologie 194:6, pages 509-519.
Crossref
Crossref
Thomas Menter & Alexandar Tzankov. (2018) Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells. Frontiers in Oncology 8.
Crossref
Crossref
Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo & Eva Lion. (2018) Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology 9.
Crossref
Crossref
J. Coy, A. Caldwell, L. Chow, A. Guth & S. Dow. (2017) PD-1 expression by canine T cells and functional effects of PD-1 blockade. Veterinary and Comparative Oncology 15:4, pages 1487-1502.
Crossref
Crossref
Romaana Mir, Heather M. Shaw & Paul D. Nathan. (2017) Immunosuppressive Agents and Their Role in Managing Immunotherapy Toxicities in Melanoma. Clinical Skin Cancer 2:1-2, pages 18-23.
Crossref
Crossref
Christina Mitteldorf, Arbeneshe Berisha, Michael Tronnier, Monique C. Pfaltz & Werner Kempf. (2017) PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma. Journal of Cutaneous Pathology 44:9, pages 740-746.
Crossref
Crossref
Johan M.J. Van den Bergh, Evelien L.J.M. Smits, Zwi N. Berneman, Tim J.A. Hutten, Hans De Reu, Viggo F.I. Van Tendeloo, Harry Dolstra, Eva Lion & Willemijn Hobo. (2017) Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion. Cancer Immunology Research 5:8, pages 710-715.
Crossref
Crossref
Christina Mitteldorf, Arbeneshe Berisha, Monique C. Pfaltz, Sigrid M.C. Broekaert, Michael P. Schön, Katrin Kerl & Werner Kempf. (2017) Tumor Microenvironment and Checkpoint Molecules in Primary Cutaneous Diffuse Large B-Cell Lymphoma—New Therapeutic Targets. American Journal of Surgical Pathology 41:7, pages 998-1004.
Crossref
Crossref
Bastian Dislich, Alexandra Stein, Christian A. Seiler, Dino Kröll, Sabina Berezowska, Inti Zlobec, José Galvan, Julia Slotta-Huspenina, Axel Walch & Rupert Langer. (2017) Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases. Cancer Immunology, Immunotherapy 66:6, pages 777-786.
Crossref
Crossref
J.K. Winkler, R. Schneiderbauer, C. Bender, O. Sedlaczek, S. Fröhling, R. Penzel, A. Enk & J.C. Hassel. (2016) Anti‐programmed cell death‐1 therapy in nonmelanoma skin cancer. British Journal of Dermatology 176:2, pages 498-502.
Crossref
Crossref
Barbara Burroni, Chlo? Broudin, Diane Damotte & Camille Laurent. (2017) Les immune-checkpoints dans les h?mopathies. Annales de Pathologie 37:1, pages 101-110.
Crossref
Crossref
Xinxin Zhu & Jinghe Lang. (2017) Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer. Journal of Gynecologic Oncology 28:5.
Crossref
Crossref
Mahmoud A Ali, Marwa Matboli, Marwa Tarek, Maged Reda, Kamal M Kamal, Mahmoud Nouh, Ahmed M Ashry, Ahmed Fath El-Bab, Hend A Mesalam, Ayman El-Sayed Shafei & Omar Abdel-Rahman. (2017) Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?. Immunotherapy 9:1, pages 99-108.
Crossref
Crossref
Giorgio Bogani, Ilaria Sabatucci, Giuseppa Maltese, Francesca Lecce, Mauro Signorelli, Fabio Martinelli, Valentina Chiappa, Alice Indini, Umberto Leone Roberti Maggiore, Chiara Borghi, Giovanni Fucà, Antonino Ditto, Francesco Raspagliesi & Domenica Lorusso. (2017) Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 208, pages 41-45.
Crossref
Crossref
Vladimir Holan, Barbora Hermankova, Pavla Bohacova, Jan Kossl, Milada Chudickova, Michaela Hajkova, Magdalena Krulova, Alena Zajicova & Eliska Javorkova. (2016) Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment. Stem Cell Reviews and Reports 12:6, pages 654-663.
Crossref
Crossref
Sha Zhou, Xin Jin, Yalin Li, Wei Li, Xiaojun Chen, Lei Xu, Jifeng Zhu, Zhipeng Xu, Yang Zhang, Feng Liu & Chuan Su. (2016) Blockade of PD-1 Signaling Enhances Th2 Cell Responses and Aggravates Liver Immunopathology in Mice with Schistosomiasis japonica. PLOS Neglected Tropical Diseases 10:10, pages e0005094.
Crossref
Crossref
Zhengbo Song, Xinmin Yu & Yiping Zhang. (2016) Altered expression of programmed death-ligand 1 after neo-adjuvant chemotherapy in patients with lung squamous cell carcinoma. Lung Cancer 99, pages 166-171.
Crossref
Crossref
Thomas Menter, Andrea Bodmer-Haecki, Stephan Dirnhofer & Alexandar Tzankov. (2016) Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas. Human Pathology 54, pages 17-24.
Crossref
Crossref
Nan Zhang, Yuanyuan Zeng, Wenwen Du, Jianjie Zhu, Dan Shen, Zeyi Liu & Jian-An Huang. (2016) The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer. International Journal of Oncology.
Crossref
Crossref
Aieska De Souza, Marianne Tinguely, Daniel R. Burghart, Arbeneshe Berisha, Kirsten D. Mertz & Werner Kempf. (2016) Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages. Journal of Cutaneous Pathology 43:7, pages 579-588.
Crossref
Crossref
S. Muenst, H. Läubli, S. D. Soysal, A. Zippelius, A. Tzankov & S. Hoeller. (2016) The immune system and cancer evasion strategies: therapeutic concepts. Journal of Internal Medicine 279:6, pages 541-562.
Crossref
Crossref
N. Stjepanovic, J.P. Velazquez-Martin & P.L. Bedard. (2016) Ocular toxicities of MEK inhibitors and other targeted therapies. Annals of Oncology 27:6, pages 998-1005.
Crossref
Crossref
Jonathan E. Schoenhals, Steven N. Seyedin, Chad Tang, Maria A. Cortez, Sharareh Niknam, Efrosini Tsouko, Joe Y. Chang, Stephen M. Hahn & James W. Welsh. (2016) Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy. The Cancer Journal 22:2, pages 130-137.
Crossref
Crossref
Jae Hun ShinHyung Bae ParkKyungho Choi. (2016) Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy. Immune Network 16:2, pages 134.
Crossref
Crossref
William Sterlacci, Michael Fiegl, Raoul A. Droeser & Alexandar Tzankov. (2016) Expression of PD-L1 Identifies a Subgroup of More Aggressive Non-Small Cell Carcinomas of the Lung. Pathobiology 83:5, pages 267-275.
Crossref
Crossref
Jonathan E. Schoenhals, Eric D. Brooks, Maria A. Cortez, Steven N. Seyedin, Sharareh Niknam, Xiaohong Wang, Alexandra P. Cadena, Xuan Shirley Li, Daniel R. Gomez, Zhongxing Liao & James W. Welsh. 2016. Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies
255
296
.
Savas D. Soysal, Alexandar Tzankov & Simone E. Muenst. (2015) Role of the Tumor Microenvironment in Breast Cancer. Pathobiology 82:3-4, pages 142-152.
Crossref
Crossref